Hypoxia-Induced Mesenchymal Stem Cell Secretome Enhances IL-10 via STAT3 Pathway in a Rat PCOS Model
Article Sidebar
Main Article Content
Abstract
Polycystic ovary syndrome (PCOS) is a condition characterized by chronic inflammation and hyperandrogenism, commonly leading to infertility. This is often triggered by hyperglycemia and hyperlipidemia, which cause hyperandrogenism. The secretome of mesenchymal stem cells (MSCs) can suppress pro-inflammatory cytokine secretion by enhancing IL-10 expression and inhibiting androgen production in a PCOS rat model. This study aims to investigate the effect of the administration of hypoxic mesenchymal stem cell secretome on IL-10 and STAT3 gene expression in the PCOS model. In vivo experimental research with a post-test-only control group design. The total sample was 24 Wistar female rats, divided into four groups: healthy, negative control (PCOS rats were injected with 0.9% NaCl), T1 (PCOS rats were given secretome at a dose of 200 µl), and T2 (PCOS rats were given Secretome at 400 µl) and were given treatment for 33 days. QRT-PCR determined IL-10 and STAT3 gene expression, and statistical analysis was performed using the One-Way ANOVA test followed by the Post Hoc LSD test. This study demonstrated that the expression of the IL-10 and STAT3 genes significantly differed in the T2 group compared to the negative control. Additionally, there was a notable difference in IL-10 gene expression between groups T2 and T1 compared to the negative control. Furthermore, differences were also observed in the expression of the STAT3 gene in both the T2 and T1 groups. The administration of hypoxic mesenchymal stem cell secretomes increased IL-10 and STAT3 gene expression in PCOS rat models.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
How to Cite
References
Deswal R, Narwal V, Dang A, Pundir CS. The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. J Hum Reprod Sci. 2020; 13(4):261-271.
Chaudhuri A. Polycystic ovary syndrome: Causes, symptoms, pathophysiology, and remedies. Obes Med. 2023; 39:100480-100489.
Hadidi M, Karimabadi K, Ghanbari E, Rezakhani L, Khazaei M. Stem cells and exosomes: as biological agents in the diagnosis and treatment of polycystic ovary syndrome (PCOS). Front Endocrinol. 2023; 14:1269266-1269276.
Prayitno GD, Lestari K, Sartika CR, Djuwantono T, Widjaya A, Muharam R, Hidayat YM, Wulandari D, Haifa R, Naura NF, Marbun KT, Zahrah A. Potential of Mesenchymal Stem Cells and Their Secretomes in Decreasing Inflammation Markers in Polycystic Ovary Syndrome Treatment: A Systematic Review. Medicines. 2022; 10(1):1-11.
Putra A, Widyatmoko A, Ibrahim S, Amansyah F, Amansyah F, Berlian MA, Retnaningsih R, Pasongka Z, Sari FE, Rachmad B. Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia. F1000Res. 2021; 10:1-19.
Chugh RM, Park H soo, El Andaloussi A, Elsharoud A, Esfandyari S, Ulin M, Bakir L, Aboalsoud A, Ali M, Ashour D, Igboeli P, Ismail N, McAllister J, Al-Hendy A. Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Res Ther. 2021;12 (1):1-19.
You M, Wang Z, Kim HJ, Lee YH, Kim HA. Pear pomace alleviated atopic dermatitis in NC/Nga mice and inhibited LPS-induced inflammation in RAW 264.7 macrophages. Nutr Res Pract. 2022; 16(5):577-588.
Tan W, Zou JL, Yoshida S, Jiang B, Zhou Y di. Increased vitreal levels of interleukin-10 in diabetic retinopathy: A Meta-analysis. Int J Ophthalmol. 2020; 13(9):1477-1483.
Prajoko YW, Putra A, Dirja BT, Muhar AM, Amalina ND. The Ameliorating Effects of MSCs in Controlling Treg-mediated B-Cell Depletion by Indoleamine 2, 3-dioxygenase Induction in PBMC of SLE Patients. Open Access Maced J Med Sci. 2022; 10:6-11.
Sunarto H, Trisnadi S, Putra A, Sa’dyah NAC, Tjipta A, Chodidjah C. The Role of Hypoxic Mesenchymal Stem Cells Conditioned Medium in Increasing Vascular Endothelial Growth Factors (VEGF) Levels and Collagen Synthesis to Accelerate Wound Healing. Ind J Can Chemoprev. 2020; 11(3): 134-141.
Xie Q, Xiong X, Xiao N, He K, Chen M, Peng J, Su X, Mei H, Dai Y, Wei D, Lin G, Cheng L. Mesenchymal Stem Cells Alleviate DHEA-Induced Polycystic Ovary Syndrome (PCOS) by Inhibiting Inflammation in Mice. Stem Cells Int. 2019; 2019(1):1-12.
Widyaningsih W, Putra A, Priyantini S, Muhar AM, Sumarawati T, Trisnadi S, Amalina ND, Alif I, Prasetio A, Irawan RC. Secretome of Hypoxia-Preconditioned Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetes Mellitus Rats. Trends in Sci. 2024; 21(5):7278-7285.
Restimulia L, Ilyas S, Munir D, Putra A, Madiadipoera T, Farhat F, Sembiring RJ, Ichwan M, Amalina D, Alif I. The CD4+CD25+FoxP3+ Regulatory T Cells Regulated by MSCs Suppress Plasma Cells in a Mouse Model of Allergic Rhinitis. Med Arch. 2021;4(75):256-261.
Dong J, Rees DA. Polycystic ovary syndrome: pathophysiology and therapeutic opportunities. BMJ Med. 2023; 2(1): 548-554.
Wang H, Feng X, Wang T, Pan J, Zheng Z, Su Y, Weng H, Zhang L, Chen L, Zhou L, Zheng L. Role and mechanism of the p-JAK2/p-STAT3 signaling pathway in follicular development in PCOS rats. Gen Comp Endocrinol. 2023; 330:114-138.
Li Y, Zheng Q, Sun D, Cui X, Chen S, Bulbul A, Liu S, Yan Q. Dehydroepiandrosterone stimulates inflammation and impairs ovarian functions of polycystic ovary syndrome. J Cell Physiol. 2019; 234(5):7435-7447.
Miki S, Suzuki J, Takashima M, Ishida M, Kokubo H, Yoshizumi M. S-1-Propenylcysteine promotes IL-10-induced M2c macrophage polarization through prolonged activation of IL-10R/STAT3 signaling. Sci Rep. 2021; 11(1):1-14.
Chugh RM, Park HS, Esfandyari S, Elsharoud A, Ulin M, Al-Hendy A. Mesenchymal stem cell-conditioned media regulate steroidogenesis and inhibit androgen secretion in a PCOS cell model via BMP-2. Int J Mol Sci. 2021; 22(17):1-12.
Afriani N, Darwin E, Ali H, Syafrita Y. The Effects of Mesenchymal Stem Cell on Calpains, Glycogen Synthase Kinase-3β, and Ryanodine Receptor 3 in Animal Models of Alzheimer’s Disease: A Systematic Review. Trop J Nat Prod Res. 2024; 8(8):7941-7946.
Baumann D, Drebant J, Hägele T, Burger L, Serger C, Lauenstein C, Dudys P, Erdmann G, Offringa R. P38 MAPK signaling in M1 macrophages results in selective elimination of M2 macrophages by MEK inhibition. J Immunother Cancer. 2021; 9(7):1-9.
Cho KA, Lee JK, Kim YH, Park M, Woo SY, Ryu KH. Mesenchymal stem cells ameliorate B-cell-mediated immune responses and increase IL-10-expressing regulatory B cells in an EBI3-dependent manner. Cell Mol Immunol. 2017; 14(11):895-908.
Fakhrurrazi F, Hakim RF, Cahyani D, Henny H, Mardhiah S. Effect of Andong (Cordyline fruticosa) Leaf Extract on the Acceleration of Incised Wound Healing of Oral Mucosa in Wistar Rats (Rattus norvegicus). Trop J Nat Prod Res. 2022; 6(1): 20-23.
Li M, Chi X, Wang Y, Setrerrahmane S, Xie W, Xu H. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022; 7(1):216-224.
Wang K, Li Y. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. Front Endocrinol. 2023; 14:1-28.
Oparaugo NC, Ouyang K, Nguyen NPN, Nelson AM, Agak GW. Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers. Int J Mol Sci. 2023; 24(2):1527-1537.
Xu Y, Tong Y, Ying J, Lei Z, Wan L, Zhu X, Ye F, Mao P, Wu X, Pan R, Peng B, Liu Y, Zhu J. Chrysin induces cell growth arrest, apoptosis, and ER stress and inhibits the activation of STAT3 through the generation of ROS in bladder cancer cells. Oncol Lett. 2018; 15 (6):9117-9125.
Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, Zeng C, Zhou T, Zhang J. NF-κB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024; 9(1):53-67.
Yang JL, Lin WL, Tai SB, Ciou YS, Chung CL, Chen JJ, Liu PF, Lin MW, Chen CL. Suppression of TGFβ-Induced Interleukin-6 Secretion by Sinulariolide from Soft Corals through Attenuation of the p38–NF-kB Pathway in Carcinoma Cells. Int J Mol Sci. 2023; 24(14):1-18.
Masyithah Darlan D, Munir D, Karmila Jusuf N, Putra A, Ikhsan R, Alif I. In vitro regulation of IL-6 and TGF-ß by mesenchymal stem cells in systemic lupus erythematosus patients. Med Glas. 2020; 17(2):408-413.